HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexei Kharitonenkov Selected Research

Adiponectin

9/2013The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.
5/2013An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexei Kharitonenkov Research Topics

Disease

20Obesity
01/2021 - 12/2008
12Body Weight (Weight, Body)
01/2021 - 12/2008
10Insulin Resistance
01/2018 - 05/2008
8Type 2 Diabetes Mellitus (MODY)
10/2014 - 01/2008
7Weight Loss (Weight Reduction)
01/2021 - 02/2007
6Dyslipidemias (Dyslipidemia)
01/2022 - 01/2012
6Metabolic Diseases (Metabolic Disease)
10/2020 - 02/2007
5Fatty Liver
01/2022 - 12/2008
3Malnutrition (Nutritional Deficiencies)
11/2020 - 05/2012
3Weight Gain
04/2016 - 06/2005
3Pancreatitis
04/2014 - 11/2009
3Hyperglycemia
02/2014 - 09/2009
2Non-alcoholic Fatty Liver Disease
10/2020 - 11/2014
2Neoplasms (Cancer)
10/2016 - 01/2014
2Glucose Intolerance
06/2015 - 02/2014
2Fibrosis (Cirrhosis)
11/2014 - 04/2014
2Starvation
04/2014 - 11/2009
2Hypothermia
04/2014 - 02/2012
2Cardiovascular Diseases (Cardiovascular Disease)
01/2013 - 04/2009
2Ketosis
11/2009 - 08/2008
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Hyperinsulinism (Hyperinsulinemia)
06/2015
1Choline Deficiency
11/2014
1Inflammation (Inflammations)
11/2014
1Diabetes Mellitus
06/2014
1Adenocarcinoma
01/2014
1Myocardial Infarction
09/2013
1Reperfusion Injury
09/2013
1Myocardial Ischemia (Ischemic Heart Diseases)
09/2013
1Glucagonoma
05/2013
1Disease Progression
01/2013
1Osteomalacia
12/2012
1Sepsis (Septicemia)
06/2012
1Acute-Phase Reaction
06/2012
1Hypoglycemia (Reactive Hypoglycemia)
06/2005

Drug/Important Bio-Agent (IBA)

39fibroblast growth factor 21IBA
01/2022 - 06/2005
13Glucose (Dextrose)FDA LinkGeneric
01/2021 - 09/2009
8Insulin (Novolin)FDA Link
10/2020 - 03/2011
6Triglycerides (Triacylglycerol)IBA
01/2018 - 11/2010
5LipidsIBA
10/2015 - 06/2012
4CholesterolIBA
10/2016 - 01/2013
4Proteins (Proteins, Gene)FDA Link
10/2014 - 01/2012
3Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2020 - 11/2009
3Fatty Acids (Saturated Fatty Acids)IBA
11/2014 - 05/2008
3CeruletideIBA
04/2014 - 11/2009
2Glucagon (Glukagon)FDA Link
01/2021 - 05/2013
2Leptin ReceptorsIBA
11/2020 - 09/2013
2Growth Hormone (Somatotropin)IBA
11/2020 - 09/2013
2Pharmaceutical PreparationsIBA
10/2016 - 04/2009
2Hormones (Hormone)IBA
10/2016 - 02/2014
2Nonesterified Fatty Acids (NEFA)IBA
04/2016 - 11/2010
2CarbohydratesIBA
10/2015 - 02/2014
2HDL CholesterolIBA
09/2013 - 02/2007
2LY2405319IBA
09/2013 - 01/2013
2AdiponectinIBA
09/2013 - 05/2013
2LDL CholesterolIBA
09/2013 - 02/2007
1Glucagon Receptors (Glucagon Receptor)IBA
01/2021
1IUB288IBA
01/2021
1Biological ProductsIBA
10/2020
1Cholic AcidIBA
01/2018
1EnzymesIBA
10/2016
1naringeninIBA
06/2015
1FlavonoidsIBA
06/2015
1Methionine (L-Methionine)FDA Link
11/2014
1Fibroblast Growth Factor 1 (FGF-1)IBA
10/2014
1Sirtuin 1IBA
02/2014
1histone H3 trimethyl Lys4IBA
01/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
09/2013
1Caspase 3 (Caspase-3)IBA
09/2013
1ApolipoproteinsIBA
09/2013
1Blood Glucose (Blood Sugar)IBA
05/2013
1Peptides (Polypeptides)IBA
05/2013
1antineoplaston A10 (A 10)IBA
01/2013
1Messenger RNA (mRNA)IBA
12/2012
1KetonesIBA
06/2012
1LeptinIBA
06/2012
1Indicators and Reagents (Reagents)IBA
01/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2009
1ThapsigarginIBA
11/2009
1Lipoproteins (Lipoprotein)IBA
02/2007

Therapy/Procedure

5Therapeutics
01/2021 - 04/2009
1Punctures
06/2012
1Ligation
06/2012
1Ketogenic Diet
08/2008